Enhancing the role of paediatric ultrasound with microbubbles: a review of intravenous applications

• Published in: British journal of radiology Vol. 90; no. 1069; p. 20160556
• Main Authors: Rafailidis, Vasileios, Deganello, Annamaria, Watson, Tom, Sidhu, Paul S, Sellars, Maria E
• Format: Journal Article
• Language: English
• Published: England The British Institute of Radiology 01.01.2017
• Subjects: Abdominal Injuries - diagnosis; Adolescent; Age Factors; Child; Child, Preschool; Contrast Media; Female; Gastrointestinal/Abdominal; Genitourinary tract; Humans; Infusions, Intravenous; Liver Diseases - diagnosis; Lung Diseases - diagnosis; Male; Microbubbles; Paediatric; Patient Safety; Pediatrics - methods; Review; Role; Sensitivity and Specificity; Ultrasonography, Doppler, Color - methods
• ISSN: 0007-1285; 1748-880X
• DOI: 10.1259/bjr.20160556

Contrast-enhanced ultrasound (CEUS) represents a complementary technique to greyscale and colour Doppler ultrasonography which allows for real-time visualization and characterization of tissue perfusion. Its inherent advantages in the child makes ultrasonography an ideal imaging modality; repeatability and good tolerance along with the avoidance of CT, a source of ionizing radiation, renders ultrasonography imaging desirable. Although currently paediatric CEUS is principally used in an "off-label" manner, ultrasonography contrast agents have received regulatory approval for assessment of paediatric focal liver lesions (FLL) in the USA. The safety of ultrasound contrast-agents is well documented in adults, as safe as or even surpassing the safety profile of CT and MR contrast agents. Except for the established intracavitary use of CEUS in voiding urosonography, i.v. paediatric applications have been introduced with promising results in the abdominal trauma initial diagnosis and follow-up, characterization and differential diagnosis of FLL and characterization of lung, pleura, renal and splenic pathology. CEUS has also been used to detect complications after paediatric transplantation, evaluate inflammatory bowel disease activity and assess tumour response to antiangiogenic therapy. The purpose of this review was to present these novel i.v. paediatric applications of CEUS and discuss their value.